CD19 and Parkinson disease: To understand the phenotypic and functional characteristics of circulating B cells in PD patients, sixteen studies (13–15, 21, 23, 29–39) reported the levels of CD19+ B cells in peripheral blood according to flow cytometry markers assessed.